Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder

NCT01238575 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01238575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01238575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder
Lead sponsor
Yale University
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2011
Completion date
March 31, 2014
Enrollment
62 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pervasive development disorders